Vertaling van "infants as protection against subsequent " (Nederlands → Frans) :

6 Velazquez F R, Matson D O, Calva J J, et al: Rotavirus infections in infants as protection against subsequent
AzimT, Van Ranst M: Predominance of rotavirus G9 genotype in children hospitalized for rotavirus gastroenteritis in

The vaccine Menveo for protection against four meningococcal meningitis serogroups was submitted in 2008 for US and EU approval and initial use from ages 11-55, with late-stage trials in infants continuing to support future submissions.
Menveo, un vaccin destiné à assurer une protection contre quatre sérogroupes de la méningite à méningocoques, a fait, en 2008, l'objet d'une demande d'autorisation aux Etats-Unis et dans l’UE pour son utilisation entre 11 et 55 ans.